Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
BPC-157 is an unapproved experimental peptide with most evidence drawn from animal studies, and human dosing remains anecdotal—typically 200 to 800 micrograms per day, often taken in cycles.
Key factors to weigh include route of administration, quality control, progress monitoring, and safety concerns. Because BPC-157 is not FDA-approved, side effects and interactions are poorly understood, making professional guidance essential.
If you're considering BPC-157 for an injury, chronic pain, or gut issues, the smartest first step is identifying what's actually causing your symptoms. A free, instant symptom check can help you pinpoint likely conditions, understand red flags, and decide whether self-care, a specialist visit, or urgent care is the right next move—before experimenting with unregulated compounds.
Reviewed for medical accuracy: 06/24/2026
Whether you're researching BPC-157 for joint pain, tendon repair, or general recovery, figuring out the right BPC-157 dosage can feel overwhelming. Here's what science tells us, what people are trying, and how to move forward safely.
Animal Studies
Lack of Human Trials
Off-Label Use
Note: These reports are informal and not a substitute for medical advice.
Range: 200–800 µg per day
Common Protocols:
Cycle Length:
Subcutaneous (SC) Injection
Intramuscular (IM) Injection
Oral (Capsules or Liquid)
Whichever route you consider, sterile technique and proper storage (refrigeration, away from light) are critical.
Unknown Long-Term Effects: There's no data on risks after months or years of use.
Quality Control Issues:
Potential Side Effects (anecdotal):
Interactions:
Start Low and Go Slow
Divide Your Dose
Track Your Progress
Source Responsibly
Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you have concerning or life-threatening symptoms, seek immediate medical attention.
(References)
* Sikiric P, Seiwerth S, Brcic L, et al. Stable Gastric Pentadecapeptide BPC 157: A Potential Therapeutic for Various Disorders. Molecules. 2021 Jul 26;26(15):4510. doi: 10.3390/molecules26154510. PMID: 34361541; PMCID: PMC8348877.
* Sikiric P, Seiwerth S, Rucman R, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2020 Feb 28;11:80. doi: 10.3389/fphar.2020.00080. PMID: 32174822; PMCID: PMC7058917.
* Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and the central nervous system. Front Pharmacol. 2024;15:1359419. Published 2024 Feb 29. doi:10.3389/fphar.2024.1359419.
* Staresinic M, Brcic L, Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 as a Prospective Therapy for Ligament Injuries: A Systematic Review. Front Pharmacol. 2024 Feb 16;15:1356499. doi: 10.3389/fphar.2024.1356499. PMID: 38435133; PMCID: PMC10906236.
* Ilic S, Drmic D, Zarkovic N, et al. BPC 157, a Novel Anti-Ulcer Peptide with an Antidepressant Like Effect and without Effect on Locomotor Activity, an in Vivo and in Vitro Study. J Physiol Pharmacol. 2010 Sep;61(5):599-605. PMID: 21087190.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.